Vol. 12 No. 3 (2024)
Published:
2024-06-30
Make a Submission
Attention
It has been brought to our notice that some organizations claim to have an association with us for publication. This is to inform all the stakeholders that the Journal of Applied Pharmaceutical Research (or any associated person) does not have any association/ affiliation/ agreement/ contract with such organizations or third-party consultancy. It has come to our attention that there might be communication from unauthorized email addresses claiming to represent us. Please be aware that any communication received from email addresses not officially recognized by us may not be legitimate and should be treated cautiously. We do not endorse such representation or disclose responsibility for actions outside our official communication channels. If you have any doubts or concerns about the authenticity of a communication received, please contact us directly through the official channels provided on our website.
"Embrace the Momentum: Now Bimonthly!"
Big News! We Hear You, Authors & Readers!
✨With immense gratitude for the overwhelming response from our cherished authors and readers, we are thrilled to unveil our latest transformation, JOAPR will be published BIMONTHLY from August 2023. ✨
Journal Policies and Information
Human, Animal rights, Informed Consent
Archive and Preservation Policy
Everyone is advised to follow these COPE Guidelines for reference and strict compliance
Visit Count
Information
Keywords
Current Issue
ISSN No. 2348-0335
Journal of Applied Pharmaceutical Research is indexed by number of agencies/ organization/ databases like SCOPUS, Directory of Open Access Journal (DOAJ), Index Copernicus, Crossref, OLCC WorldCat, Garuda, Dimensions, Chemical Abstract Services (CAS), OpenAIRE, Google Scholar, J-Gate, Scilit, International Committee of Medical Journal Editors (ICMJE), Indonesia one search, Indian Citation Index, CNKI, Bielefeld Academic Search Engine (BASE), PKP-Index, Neliti
@2023 The Author(s). This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
